Pre-Surgical Study: Effect of Metformin on Breast Cancer Proliferation

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 16, 2009

Primary Completion Date

May 10, 2012

Study Completion Date

January 9, 2017

Conditions
Breast Cancer
Interventions
DRUG

Metformin

1500 mg per day, divided 500 mg in the morning and 1000 mg in the evening, for at least two weeks prior to surgery

Trial Locations (1)

10032

Columbia University Irving Medical Center, New York

Sponsors
All Listed Sponsors
collaborator

Breast Cancer Research Foundation

OTHER

lead

Columbia University

OTHER

NCT00930579 - Pre-Surgical Study: Effect of Metformin on Breast Cancer Proliferation | Biotech Hunter | Biotech Hunter